Table 3.
Comparison between the 26 R0 patient in relationship to the adjuvant mitotane therapy.
Adjuvant mitotane | No adjuvant therapy | p | |
---|---|---|---|
N | 17 | 9 | |
Age at diagnosis | 45.1 ± 16.0 | 53.9 ± 19.9 | 0.2 |
Tumor size | 9.4 ± 3.8 | 8.4 ± 4.0 | 0.5 |
Functioning tumors | 10 | 3 | 0.4 |
Stage III–IV | 7 | 1 | 0.2 |
Recurrence | 8 | 4 | 0.9 |